# Omnipod® 5 With Libre 2 vs. MDI for Type 1 Diabetes in Children and Adults

> **NCT05923827** · NA · COMPLETED · sponsor: **Insulet Corporation** · enrollment: 189 (actual)

## Conditions studied

- Diabetes Mellitus, Type 1

## Interventions

- **DEVICE:** Omnipod 5 System

## Key facts

- **NCT ID:** NCT05923827
- **Lead sponsor:** Insulet Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-09-11
- **Primary completion:** 2024-08-16
- **Final completion:** 2026-02-12
- **Target enrollment:** 189 (ACTUAL)
- **Last updated:** 2026-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05923827

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05923827, "Omnipod® 5 With Libre 2 vs. MDI for Type 1 Diabetes in Children and Adults". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05923827. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*